Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M T Lotze

Showing results (151-160 of 242) with videos related to

Pageof 25
Sort By:
Cancer Research|April 15, 1987
In vivo administration of purified human interleukin-2 to patients with cancer: development of interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors following interleukin-2 administrationM T Lotze, M C Custer, S O Sharrow, et al.
Cancer Gene Therapy|June 11, 1998
Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cellsB Couderc, L Zitvogel, V Douin-Echinard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancerM J Robertson, C Cameron, M B Atkins, et al.
Cancer Research|April 29, 2000
CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodesM Hirao, N Onai, K Hiroishi, et al.
The Journal of Experimental Medicine|January 1, 1996
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokinesL Zitvogel, J I Mayordomo, T Tjandrawan, et al.
Cell Death & Disease|December 17, 2013
Strange attractors: DAMPs and autophagy link tumor cell death and immunityW Hou, Q Zhang, Z Yan, et al.
European Journal of Immunology|November 1, 1996
Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytesM J Maeurer, H W Chan, J Karbach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1995
Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblastsL Zitvogel, H Tahara, P D Robbins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 20, 1998
IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effectsT Osaki, J M Péron, Q Cai, et al.
The Laryngoscope|February 24, 1998
Interleukin-12 gene therapy prevents establishment of SCC VII squamous cell carcinomas, inhibits tumor growth, and elicits long-term antitumor immunity in syngeneic C3H miceJ N Myers, A Mank-Seymour, L Zitvogel, et al.
Pageof 25

Showing results (151-160 of 242) with videos related to

Sort By:
Pageof 25
Cancer Research|April 15, 1987
In vivo administration of purified human interleukin-2 to patients with cancer: development of interleukin-2 receptor positive cells and circulating soluble interleukin-2 receptors following interleukin-2 administrationM T Lotze, M C Custer, S O Sharrow, et al.
Cancer Gene Therapy|June 11, 1998
Enhancement of antitumor immunity by expression of CD70 (CD27 ligand) or CD154 (CD40 ligand) costimulatory molecules in tumor cellsB Couderc, L Zitvogel, V Douin-Echinard, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 26, 1999
Immunological effects of interleukin 12 administered by bolus intravenous injection to patients with cancerM J Robertson, C Cameron, M B Atkins, et al.
Cancer Research|April 29, 2000
CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodesM Hirao, N Onai, K Hiroishi, et al.
The Journal of Experimental Medicine|January 1, 1996
Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell 1-associated cytokinesL Zitvogel, J I Mayordomo, T Tjandrawan, et al.
Cell Death & Disease|December 17, 2013
Strange attractors: DAMPs and autophagy link tumor cell death and immunityW Hou, Q Zhang, Z Yan, et al.
European Journal of Immunology|November 1, 1996
Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytesM J Maeurer, H W Chan, J Karbach, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1995
Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblastsL Zitvogel, H Tahara, P D Robbins, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 20, 1998
IFN-gamma-inducing factor/IL-18 administration mediates IFN-gamma- and IL-12-independent antitumor effectsT Osaki, J M Péron, Q Cai, et al.
The Laryngoscope|February 24, 1998
Interleukin-12 gene therapy prevents establishment of SCC VII squamous cell carcinomas, inhibits tumor growth, and elicits long-term antitumor immunity in syngeneic C3H miceJ N Myers, A Mank-Seymour, L Zitvogel, et al.
Pageof 25